首页> 外文期刊>The Environmental Law Reporter >The Regulation of Genetically Modified Organisms: Why the Biotech Products Case Is a Win-Win Situation for the European Union
【24h】

The Regulation of Genetically Modified Organisms: Why the Biotech Products Case Is a Win-Win Situation for the European Union

机译:转基因生物法规:为什么生物技术产品案是欧盟的双赢局面

获取原文
获取原文并翻译 | 示例
           

摘要

The United States and the EU currently stand in discord over the safety and value of GMOs in agricultural products. The disagreement culminated in a 2006 WTO Dispute Resolution Panel ruling in favor of the EU's use of discretionary, protectionist measures when regulating GMOs. In this Article, Jonathan Dorn explores whether international trade can co-exist with environmental protection. He offers background of the differing views on GMOs, explains the U.S. rationale for filing the dispute with the WTO, and argues that the Biotech Products case is a win-win situation for the EU.
机译:美国和欧盟目前在农产品中转基因生物的安全性和价值上存在分歧。分歧最终在2006年WTO争端解决小组中做出裁决,该裁决赞成欧盟在监管转基因生物时采用酌情的保护主义措施。在本文中,乔纳森·多恩(Jonathan Dorn)探讨了国际贸易是否可以与环境保护并存。他提供了有关转基因生物不同观点的背景,解释了美国向WTO提出争端的理由,并辩称生物技术产品案是欧盟的双赢局面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号